From pandemic test tubes to the cancer challenge

Phase Scientific made its name with Indicaid, a rapid antigen test that received US emergency-use authorisation in July 2021, was used in Hong Kong's community testing and was sold in more than 30 countries. From a team of 20 to 30 people at the start of the pandemic, the company grew to around 400 employees, at one point producing as many as 30 million tests a month.

Yet what stands out is not the growth figures but the choice that followed. As demand for test kits subsided, Ricky Chiu decided to reinvest the company's Covid profits into cancer research, treating the capital, manufacturing know-how and team it had built as a launch pad rather than a destination.

Covid gave us the capital, the experience and the team. The question was what problem we wanted to tackle next.

- Ricky Chiu

Five particles in a cup of water

At the heart of Phase's technology is the concentration of biological material already present in a liquid sample before it is tested. For cervical screening, a woman collects her own urine, which a laboratory then processes to gather the traces of HPV that researchers are looking for.